Randomized double-blind trial examines acute cardiorespiratory responses to inhaled graphene oxide nanosheets in humans, highlighting potential health effects of engineered nanomaterials.
Graphene oxide nanomaterials are being developed for wide-ranging applications but are associated with potential safety concerns for human health. We conducted a double-blind randomized controlled study to determine how the inhalation of graphene oxide nanosheets affects acute pulmonary and cardiovascular function. Small and ultrasmall graphene oxide nanosheets at a concentration of 200 μg m
No takes yet. Share an insight, caveat, or question.
Andrews et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: